Christopher Peetz

CHIEF EXECUTIVE OFFICER

Christopher Peetz (CHIEF EXECUTIVE OFFICER) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales), most often in Mirum Pharmaceuticals, Inc. (MIRM). The largest single filing was $3.8M of MIRM (40,985 sh × $91.98, as filed), executed Mar 16.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 8 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$16.2M

shares × price, as filed

Last traded

Sep 1

Filed Sep 3

Median ADV $83.1M across their filed names

Open performance→

Volume by month

Buys $0 Sells $25.1M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 8 filings

Sector per market data · by filing · past 12 months

Most traded names

MIRM

Mirum Pharmaceuticals, Inc. MIRM · 0 buys · 15 sells 15 filings

Recent filings

MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $3.0M
30,000 sh across 2 lots
Exec Sep 1
Filed Sep 3 · 6:52 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $2.0M
20,000 sh across 3 lots
Exec Aug 10
Filed Aug 11 · 5:41 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $2.4M
20,000 sh across 4 lots
Exec Jul 6
Filed Jul 8 · 5:12 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $2.8M
29,117 sh across 5 lots
Exec Jun 1
Filed Jun 2 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $3.8M
40,985 sh × $91.98
Exec Mar 16
Filed Mar 17 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $941K
9,108 sh × $103.30
Exec Feb 2
Filed Feb 3 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $657K
6,831 sh × $96.19
Exec Jan 26
Filed Jan 27 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $662K
7,098 sh × $93.33
Exec Jan 22
Filed Jan 23 · 5:30 PM ET More filings →